FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services home page

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

HIV and AIDS
Human Immunodeficiency Virus and
Acquired Immunodeficiency Syndrome

current May 2007

Generic Drugs Used in the Treatment

of HIV Infection

Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

Generic Name Manufacturer Name Approval Date Time to Approval
didanosine (ddI)
Delayed Release capsules
Barr Laboratories, Inc. 03-Dec-04 6 months
didanosine (ddI)
for
oral solution (pediatric powder), 10 mg/mL
Aurobindo Pharma Limited 08-March-07 14 months
zidovudine Oral Solution USP, 50 mg/5 mL, Oral Solution - zidovudine, AZT, azidothymidine, ZDV (Pediatric formulation - 50 mg/ 5 mL) Aurobindo Pharma Limited 19-Sep-05 6 months
zidovudine Oral Solution USP, 50 mg/5 mL, Oral Solution - zidovudine, AZT, azidothymidine, ZDV (Pediatric formulation - 50 mg/ 5 mL) Cipla Limited 25-Jun-2008 8 months
zidovudine, AZT, azidothymidine, ZDV (300 mg tablet) Aurobindo Pharma Limited 19-Sep-05 10 months
zidovudine, AZT, azidothymidine, ZDV (300 mg tablet) Ranbaxy Laboratories Limited 19-Sep-05 11 months
zidovudine, AZT, azidothymidine, ZDV (300 mg tablet) Roxane Laboratories 19-Sep-05 24 months
zidovudine, AZT, azidothymidine, ZDV (300 mg tablet) Matrix Laboratories, Inc.
14-Feb-08 11 months
zidovudine, AZT, azidothymidine, ZDV (100 mg capsule) Aurobindo Pharma LTD. 27-March--06 4 months
zidovudine, AZT, azidothymidine, ZDV (100 mg capsule) Cipla Limited 23-May-2007 11 months

Drugs Used in the Treatment of HIV Infection (approved innovator products)

Drugs Used in the Treatment of Pediatric HIV Infection (approved innovator products)

horizontal rule

HIV/AIDS Home Page